Antimicrobial resistance: Factors and outcomes

被引:43
作者
Fish, Douglas N.
Ohlinger, Martin J.
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Clin Pharm, Denver, CO 80262 USA
[2] Univ Colorado Hosp, Dept Pharm, Denver, CO 80262 USA
[3] Univ Toledo, Coll Pharm, Dept Pharm Practice, Toledo, OH 43606 USA
[4] Med Univ Ohio, Med Ctr, Toledo, OH 43606 USA
关键词
D O I
10.1016/j.ccc.2006.02.006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Antimicrobial resistance in the ICU is characterized by increasing overall resistance rates among gram-negative and gram-positive pathogens and increased frequency of multidrug-resistant organisms. In addition to basic principles of appropriate drug selection for empiric and definitive therapy, other specific strategies that may decrease problems of resistance through improved use of antimicrobials include appropriate application of pharmacokinetic and pharmacodynamic principles to antimicrobial use, aggressive dosing of antimicrobials, use of broad-spectrum and combination antimicrobial therapy for initial treatment, decreased duration of antimicrobial therapy, hospital formulary-based antimicrobial restrictions, use of antimicrobial protocols and guidelines, programs for restriction of target antimicrobials, scheduled antimicrobial rotation, and use of antimicrobial management programs. Combinations of various approaches may offer the best potential for effectively intervening in and reducing the spread of resistant pathogens in critically ill patients.
引用
收藏
页码:291 / +
页数:22
相关论文
共 96 条
[1]   The epidemiology of hematogenous candidiasis caused by different Candida species [J].
AbiSaid, D ;
Anaissie, E ;
Uzun, O ;
Raad, I ;
Pinzcowski, H ;
Vartivarian, S .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) :1122-1128
[2]   Consequences of bacterial resistance to antibiotics in medical practice [J].
Acar, JF .
CLINICAL INFECTIOUS DISEASES, 1997, 24 :S17-S18
[3]   Drug resistance in intensive care units [J].
Albrich, WC ;
Angstwurm, M ;
Bader, L ;
Gärtner, R .
INFECTION, 1999, 27 (Suppl 2) :S19-S23
[4]   Two consecutive outbreaks of Stenotrophomonas maltophilia (Xanthomonas maltophilia) in an intensive-care unit defined by restriction fragment-length polymorphism typing [J].
Alfieri, N ;
Ramotar, K ;
Armstrong, P ;
Spornitz, ME ;
Ross, G ;
Winnick, J ;
Cook, DR .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (08) :553-556
[5]   Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit [J].
AlvarezLerma, F ;
Pellus, AM ;
Sanchez, BA ;
Ortiz, EP ;
Jorda, R ;
Barcenilla, F ;
Maravi, E ;
Galvan, B ;
Palomar, M ;
Serra, J ;
Bermejo, B ;
Mateu, A ;
Quintana, E ;
Palacios, MS ;
Giral, R ;
Gonzalez, V ;
Lerma, FA ;
Mesa, JL ;
Melgarejo, JA ;
Martinez, J ;
Insausti, J ;
Olaechea, P ;
Chanovas, M ;
Gilabert, A ;
Junquera, C ;
Valles, J ;
Palacios, F ;
Calvo, R ;
Mesalles, E ;
Nava, J ;
Santos, A ;
Armengol, S ;
Marzo, D .
INTENSIVE CARE MEDICINE, 1996, 22 (05) :387-394
[7]   Antimicrobial resistance in isolates from inpatients and outpatients in the united states: Increasing importance of the intensive care unit [J].
Archibald, L ;
Phillips, L ;
Monnet, D ;
McGowan, JE ;
Tenover, F ;
Gaynes, R .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :211-215
[8]   External sources of vancomycin-resistant enterococci for intensive care units [J].
Bonten, MJM ;
Slaughter, S ;
Hayden, MK ;
Nathan, C ;
van Voorhis, J ;
Weinstein, RA .
CRITICAL CARE MEDICINE, 1998, 26 (12) :2001-2004
[9]   Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia [J].
Boselli, E ;
Breilh, D ;
Duflo, F ;
Saux, MC ;
Debon, R ;
Chassard, D ;
Allaouchiche, B .
CRITICAL CARE MEDICINE, 2003, 31 (08) :2102-2106
[10]   Monotherapy versus combination therapy for bacterial infections [J].
Bouza, E ;
Muñoz, P .
MEDICAL CLINICS OF NORTH AMERICA, 2000, 84 (06) :1357-+